09.23.25 -- Optimizing Lentiviral Vectors For Allogeneic CAR-T Manufacturing

Residues from cleaning agents can pose significant risks to cleanroom operations. Learn about residue management, measurement techniques, and best practices to ensure compliance and product safety.

Discover a streamlined dPCR-based workflow for precise lentiviral vector quantification to support safer, more consistent cell and gene therapies through accurate genome titer, VCN, and RCL assessment.

Keep your cells thriving. Learn the essential cell culture media change protocol, including frequency, steps, and tips for optimal cell growth. Discover best practices and avoid common pitfalls.

From donor variability to collection site inconsistencies, cell and gene therapy faces raw material challenges. Ensuring stable, high-quality leukopaks is vital for effective treatments.

Cell and gene therapy has evolved from a niche concept to a booming sector in just five years, with over 1,300 companies and growing momentum in innovation, investment, and regulatory approvals.

A serum replacement for promoting T cell growth and functionality in cell therapy development shows comparable or superior performance to traditional human serum supplements.

Here we explore the use of viral vectors in gene therapies, as well as factors that negatively affect them during manufacturing.

This scientific brief reviews how high-performance syringe filters protect and extend the life of analytical HPLC and UHPLC instruments and columns.

EV production scale increases require paired robust, scalable, and cost-effective downstream processes. Process parameters can be tailored to allow for maximum exosome recovery.

Learn about a modular and compact filling and closing system for flexibility in pharmaceutical manufacturing operations and automated processing of vials, syringes, and cartridges.

Watch to learn about solutions to address challenges in standardizing flow cytometry and cell analysis solutions that support drug development at every stage.